Reply - 05/11/19
Doi : 10.1016/j.jaci.2019.08.012
Sabine Flicker, PhD a, Musa Khaitov, PhD b, Rudolf Valenta, MD a, b, c 
a Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
b National Research Center, Institute of Immunology FMBA of Russia, Moscow, Russia
c Laboratory of Immunopathology, Department of Clinical Immunology and Allergy, Sechenov First Moscow State Medical University, Moscow, Russia
Il testo completo di questo articolo è disponibile in PDF.
| Disclosure of potential conflict of interest: S. Flicker is supported by the Austrian Science Fund, FWF (grant no. F4607). R. Valenta receives grant support from the Austrian Science Fund (FWF) (grant no. F4605) and Viravaxx, Vienna, Austria; is recipient of a megagrant of the Government of the Russian Federation (grant no. 14.W03.31.0024), and serves as a consultant for Viravaxx, Vienna, Austria. M. Khaitov declares no relevant conflicts of interest. |
© 2019
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 144 - N° 5
P. 1455-1456 - novembre 2019 Ritorno al numero
Articolo precedente
- Does maternal IgG protect infants from allergen-specific IgE sensitization?
- Rob C. Aalberse, Ulrike Gehring, Marjan Tewis, Theo Rispens
- Corrigenda
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?